* Health and Medical News:J&J can weather new biotech threat: Analyst

Cheaper biotech drugs are headed to the U.S., but one analyst thinks J&J can manage through some of the challenges.

from @ Health and Medical News http://ift.tt/1c5FsQt
via Health and Medical NewsHealth and Medical News Pfizer Inc has already had its takeover overtures rebuffed three times by rival AstraZeneca Plc, but investors in the U.S. drugmaker say it can tolerate a little more rejection before going hostile with the deal. AstraZeneca turned down a sweeten...

Popular Health News